Market Cap 1.32B
Revenue (ttm) 2.25B
Net Income (ttm) -1.18B
EPS (ttm) N/A
PE Ratio 6.97
Forward PE 6.35
Profit Margin -52.69%
Debt to Equity Ratio 0.87
Volume 816,693
Avg Vol 1,137,704
Day's Range N/A - N/A
Shares Out 57.25M
Stochastic %K 17%
Beta 1.46
Analysts Strong Sell
Price Target $45.18

Company Profile

Enovis Corporation, a medical technology company, focuses on developing clinically differentiated solutions in the United States and internationally. It operates through two segments: Prevention and Recovery, and Reconstructive segments. The Prevention and Recovery segment offers rigid and soft orthopedic bracing, hot and cold therapy, bone growth stimulators, vascular therapy systems and compression garments, electrical stimulators for pain management, and physical therapy products which are us...

Industry: Medical Devices
Sector: Healthcare
Phone: 302 252 9160
Address:
2711 Centerville Road, Suite 400, Wilmington, United States
NakedDayTrader4
NakedDayTrader4 Mar. 11 at 1:53 AM
$ENOV great earnings and analysts upgrades…with price targets $20 dollars higher.,..still cant move this stock. It’s simply unloved
0 · Reply
TI7812
TI7812 Mar. 4 at 6:20 PM
$ENOV good sign stock holding in $25 range during this huge market volatility after the big ER pop from the $22 range. analysts price targets as high as $52 FY26 guide for Adj EPS $3.52 to $3.73 the chart speaks of PMs dumping for like 2 years plus Anyone have a feel for will they be able to meet their guidance?
0 · Reply
SocioCobb
SocioCobb Feb. 26 at 8:41 PM
$ENOV September form 4 (decent size) at $31. This one has room to run higher, imo. In the meantime, here's what I'd look like as a black man 👀.
0 · Reply
NakedDayTrader4
NakedDayTrader4 Feb. 26 at 3:16 PM
$ENOV excellent qtr and raised guidance. I have no idea why this got beaten down so bad the past month or two. It’s a money making machine in a fast growing sector.
1 · Reply
StocktwitsEarnings
StocktwitsEarnings Feb. 26 at 11:29 AM
$ENOV Q4 '25 Earnings Results & Recap • Reported GAAP EPS of -$9.10 up 27.95% YoY • Reported revenue of $575.76M up 2.64% YoY • Enovis expects 2026 revenue of $2.31B, with 4-6% organic growth. Adjusted EBITDA is projected at $425M, and adjusted EPS is anticipated to be $3.52 to $3.73.
0 · Reply
Abdul92z
Abdul92z Feb. 7 at 12:46 PM
$PATH & $ENOV 👀
0 · Reply
AccountAscender
AccountAscender Feb. 4 at 2:17 PM
$ENOV is a provider of software and services for product lifecycle management; it operates in a niche market with stable demand from manufacturing clients.
0 · Reply
The_Trading_Mechanic
The_Trading_Mechanic Jan. 30 at 12:50 PM
ENOVis trading at major long-term support, sitting near levels last seen during the 2020 lows and areas that previously acted as key support during the 2009 cycle. These zones represent historically significant demand areas where buyers have stepped in before. A decisive push through the $29.00 level would confirm a trend shift and open the door for a move toward the $37.98 resistance, offering strong upside from current prices. With a clearly defined stop loss at $20.00, this setup presents an excellent risk-to-reward ratio, making ENOV an attractive rebound and value recovery play. If you enjoy my analysis and want to see more trade ideas like this, your support means the world to me! Consider liking, sharing, or following for more deep dives into market opportunities.
0 · Reply
stockRDA
stockRDA Jan. 28 at 11:33 PM
$ENOV this starting to hurt right now….
0 · Reply
NakedDayTrader4
NakedDayTrader4 Jan. 28 at 4:37 PM
$ENOV shorts having their way with this
1 · Reply
Latest News on ENOV
Royce Small-Cap Fund FY 2025: What Worked

Mar 9, 2026, 3:55 AM EDT - 8 days ago

Royce Small-Cap Fund FY 2025: What Worked

AGI MLAB PAR SII STRL TMDX TRNS


Enovis Corporation (ENOV) Q4 2025 Earnings Call Transcript

Feb 27, 2026, 2:27 AM EST - 18 days ago

Enovis Corporation (ENOV) Q4 2025 Earnings Call Transcript


Enovis Announces Fourth Quarter and Full Year 2025 Results

Feb 26, 2026, 6:10 AM EST - 19 days ago

Enovis Announces Fourth Quarter and Full Year 2025 Results


Top 3 Health Care Stocks That Could Blast Off This Month

Jan 21, 2026, 6:41 AM EST - 7 weeks ago

Top 3 Health Care Stocks That Could Blast Off This Month

HIMS TVTX


Enovis Appoints Oliver Engert as Chief Administrative Officer

Jan 5, 2026, 4:15 PM EST - 2 months ago

Enovis Appoints Oliver Engert as Chief Administrative Officer


Enovis Corporation (ENOV) Q3 2025 Earnings Call Transcript

Nov 6, 2025, 8:26 PM EST - 4 months ago

Enovis Corporation (ENOV) Q3 2025 Earnings Call Transcript


Enovis Announces Third Quarter 2025 Results

Nov 6, 2025, 6:01 AM EST - 4 months ago

Enovis Announces Third Quarter 2025 Results


Enovis: Healthy Recon Trends Vs. Market Apathy

Aug 27, 2025, 8:24 AM EDT - 7 months ago

Enovis: Healthy Recon Trends Vs. Market Apathy


Enovis to Participate in Upcoming Investor Conferences

Aug 8, 2025, 9:00 AM EDT - 7 months ago

Enovis to Participate in Upcoming Investor Conferences


Enovis Corporation (ENOV) Q2 2025 Earnings Call Transcript

Aug 8, 2025, 3:25 AM EDT - 7 months ago

Enovis Corporation (ENOV) Q2 2025 Earnings Call Transcript


Enovis Announces Second Quarter 2025 Results

Aug 7, 2025, 6:00 AM EDT - 7 months ago

Enovis Announces Second Quarter 2025 Results


Enovis Corporation (ENOV) Q1 2025 Earnings Call Transcript

May 11, 2025, 1:46 AM EDT - 11 months ago

Enovis Corporation (ENOV) Q1 2025 Earnings Call Transcript


Enovis Announces First Quarter 2025 Results

May 8, 2025, 6:00 AM EDT - 11 months ago

Enovis Announces First Quarter 2025 Results


Enovis Continues To Languish Despite Decent Financial Results

Feb 28, 2025, 8:23 AM EST - 1 year ago

Enovis Continues To Languish Despite Decent Financial Results


Enovis Corporation (ENOV) Q4 2024 Earnings Call Transcript

Feb 26, 2025, 12:53 PM EST - 1 year ago

Enovis Corporation (ENOV) Q4 2024 Earnings Call Transcript


Enovis Announces Fourth Quarter and Full Year 2024 Results

Feb 26, 2025, 6:01 AM EST - 1 year ago

Enovis Announces Fourth Quarter and Full Year 2024 Results


Enovis Announces Planned CEO Succession Process

Feb 26, 2025, 6:00 AM EST - 1 year ago

Enovis Announces Planned CEO Succession Process


Enovis Corporation: Reasonably Valued With Caveats

Nov 22, 2024, 12:17 PM EST - 1 year ago

Enovis Corporation: Reasonably Valued With Caveats


Enovis Corporation (ENOV) Q3 2024 Earnings Call Transcript

Nov 6, 2024, 12:50 PM EST - 1 year ago

Enovis Corporation (ENOV) Q3 2024 Earnings Call Transcript


Enovis Announces Third Quarter 2024 Results

Nov 6, 2024, 6:00 AM EST - 1 year ago

Enovis Announces Third Quarter 2024 Results


Enovis Announces Second Quarter 2024 Results

Aug 7, 2024, 6:00 AM EDT - 1 year ago

Enovis Announces Second Quarter 2024 Results


Enovis Languishing Despite Respectable Performance

Jul 15, 2024, 12:58 AM EDT - 1 year ago

Enovis Languishing Despite Respectable Performance


Top 3 Health Care Stocks That Could Blast Off In June

Jun 21, 2024, 8:22 AM EDT - 1 year ago

Top 3 Health Care Stocks That Could Blast Off In June

PEN RGEN


NakedDayTrader4
NakedDayTrader4 Mar. 11 at 1:53 AM
$ENOV great earnings and analysts upgrades…with price targets $20 dollars higher.,..still cant move this stock. It’s simply unloved
0 · Reply
TI7812
TI7812 Mar. 4 at 6:20 PM
$ENOV good sign stock holding in $25 range during this huge market volatility after the big ER pop from the $22 range. analysts price targets as high as $52 FY26 guide for Adj EPS $3.52 to $3.73 the chart speaks of PMs dumping for like 2 years plus Anyone have a feel for will they be able to meet their guidance?
0 · Reply
SocioCobb
SocioCobb Feb. 26 at 8:41 PM
$ENOV September form 4 (decent size) at $31. This one has room to run higher, imo. In the meantime, here's what I'd look like as a black man 👀.
0 · Reply
NakedDayTrader4
NakedDayTrader4 Feb. 26 at 3:16 PM
$ENOV excellent qtr and raised guidance. I have no idea why this got beaten down so bad the past month or two. It’s a money making machine in a fast growing sector.
1 · Reply
StocktwitsEarnings
StocktwitsEarnings Feb. 26 at 11:29 AM
$ENOV Q4 '25 Earnings Results & Recap • Reported GAAP EPS of -$9.10 up 27.95% YoY • Reported revenue of $575.76M up 2.64% YoY • Enovis expects 2026 revenue of $2.31B, with 4-6% organic growth. Adjusted EBITDA is projected at $425M, and adjusted EPS is anticipated to be $3.52 to $3.73.
0 · Reply
Abdul92z
Abdul92z Feb. 7 at 12:46 PM
$PATH & $ENOV 👀
0 · Reply
AccountAscender
AccountAscender Feb. 4 at 2:17 PM
$ENOV is a provider of software and services for product lifecycle management; it operates in a niche market with stable demand from manufacturing clients.
0 · Reply
The_Trading_Mechanic
The_Trading_Mechanic Jan. 30 at 12:50 PM
ENOVis trading at major long-term support, sitting near levels last seen during the 2020 lows and areas that previously acted as key support during the 2009 cycle. These zones represent historically significant demand areas where buyers have stepped in before. A decisive push through the $29.00 level would confirm a trend shift and open the door for a move toward the $37.98 resistance, offering strong upside from current prices. With a clearly defined stop loss at $20.00, this setup presents an excellent risk-to-reward ratio, making ENOV an attractive rebound and value recovery play. If you enjoy my analysis and want to see more trade ideas like this, your support means the world to me! Consider liking, sharing, or following for more deep dives into market opportunities.
0 · Reply
stockRDA
stockRDA Jan. 28 at 11:33 PM
$ENOV this starting to hurt right now….
0 · Reply
NakedDayTrader4
NakedDayTrader4 Jan. 28 at 4:37 PM
$ENOV shorts having their way with this
1 · Reply
OfficialStocktwitsUser
OfficialStocktwitsUser Jan. 27 at 9:55 PM
$ENOV RSI: 23.24, MACD: -1.3749 Vol: 2.27, MA20: 25.56, MA50: 27.05 ⚪ HOLD - Sideways 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.
0 · Reply
NakedDayTrader4
NakedDayTrader4 Jan. 20 at 10:55 PM
$ENOV I stand corrected, I’m now convinced we’re never going up again😂
1 · Reply
NakedDayTrader4
NakedDayTrader4 Jan. 20 at 12:42 AM
$ENOV guess we’ll lose another 5% tomorrow..on top of the 20% we lost in just the past 5 trading days. Ridiculous.
1 · Reply
stockRDA
stockRDA Jan. 16 at 9:54 PM
$ENOV valuation is absurd.
0 · Reply
NakedDayTrader4
NakedDayTrader4 Jan. 14 at 5:07 PM
$ENOV look on the bright aside, it can’t go down forever?
0 · Reply
NakedDayTrader4
NakedDayTrader4 Jan. 14 at 4:53 PM
$ENOV tragic.
0 · Reply
NakedDayTrader4
NakedDayTrader4 Jan. 12 at 8:07 PM
$ENOV they raised earnings estimates but lowered top line revs..and it’s down 9%?! 🤣 down that mean their margins are rising?
0 · Reply
momyurich
momyurich Jan. 12 at 4:55 PM
$ENOV initiated 👍📈
0 · Reply
momyurich
momyurich Jan. 7 at 3:52 PM
$ENOV 👍📈
0 · Reply
OfficialStocktwitsUser
OfficialStocktwitsUser Jan. 1 at 12:54 PM
$ENOV RSI: 43.70, MACD: -0.5630 Vol: 0.71, MA20: 27.16, MA50: 29.13 ⚪ HOLD - Sideways 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.
0 · Reply
JarvisFlow
JarvisFlow Dec. 17 at 8:14 PM
Canaccord Genuity updates rating for Enovis ( $ENOV ) to Buy, target set at 58 → 50.
0 · Reply
JarvisFlow
JarvisFlow Dec. 17 at 3:04 PM
Freedom Capital Markets updates rating for Enovis ( $ENOV ) to Buy, target set at 45.
0 · Reply